A drug industry-funded conservative policy group suggested that 340B reform “should be a priority” for large scale government cost-cutting efforts [...] …
Articles by : Bella Czajkowski, National Correspondent
A California-based hospital has sued the Health Resources and Services Administration (HRSA), alleging the agency unlawfully prevented it from accessing [...] …
Connecticut hospitals, pharmacy benefit managers (PBMs), pharmacies and insurance companies would have to report how much they charge patients for [...] …
A provision in a 2021 COVID-19 relief bill that sought to lower prescription drug prices has actually made some medications [...] …
The Department of Health and Human Services (HHS) announced the second group of high-cost prescription drugs chosen for Medicare price [...] …
The House Energy and Commerce (E&C) Committee, which has jurisdiction over the 340B and Medicaid programs, held its first meeting [...] …
Drugmakers Bristol Myers Squibb (BMS) and Vertex have each announced changes to their 340B contract pharmacy restrictions that apply to [...] …
Participation in the 340B program did not increase the number of vulnerable patients beginning targeted care for prostate cancer, a [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Four drugmakers have notified 340B covered entities of changes to certain national drug codes (NDC) for their products over the [...] …